Tron Logo
Trade on HitBTC
Like this video
Suspicious ICO. Please read this Bitcointalk post before investing: https://bitcointalk.org/index.php?topic=4679775.0

MeFy

Future of Decentralised Healthcare Platform

Mefy works on a subscription-based model, where the user of MeMe Care subscribes for yearly subscription allowing them any number of tests throughout the year for the cost of just consumables. Through its eConsult feature it connects worldwide doctors to worldwide patients thereby resolving accessibility issues and with its MeMe Edge device, it provides authenticity to the test conducted.

2.8
1 0 expert ratings
Benchy 2.8
KYC
Experts
-
-
-
Review: coming soon PRO

Unknown
Token
MEFY
Type
Bounty
Platform
Accepting
BTC, ETH, XMV
Minimum investment
0.5 ETH
Soft cap
10,000,000 USD
Country
Visit ICO website
Report

About MeFy

MeFy is an integrated health platform that provides a platform for everyone to play its role for the betterment of society and individuals’ health. Starting from an individual to his / her friends and family, from doctors to pharmacists, hospitals to pharmaceutical companies, researchers to government institutions.

MeFy intends to build a private cloud and tightly integrate with a private blockchain to enable participation and data sharing across platform.

MeFy will use the blockchain not to just create health records and share but will also enable auto health record creation through IOT enabled MeMe Edge device. Every prescription written by the doctor using MeMe eConsult will not be stored as an image or file, but every detail entered by the doctor will contribute to user health record be it the diagnosis done by the doctor or the medication prescribed by the doctor or a lifestyle correction advised by doctor.

This will be followed with diet and lifestyle management through the MeMe Care App. The social platform will enable the individuals to share home remedies and health tips as well as allowing researchers to publish white papers and get paid for the hard work.

Retail pharmacies will be able to manage their inventory and supply chain using MeMe Smart AI Supply Chain. Pharmaceutical companies can leverage this data to manufacture what is required by gaining access to MeFy private blockchain via smart contracts. Hospitals and clinicians outside of MeFy private cloud can gain authorised access to individual health data as per the smart contract. Researchers and  overnment institution will have aggregated data to control spread of diseases and plan future drugs.

Lastly, MeMe Edge powered by AI will possess capabilities to generate auto prescription for off-the-self medicine by processing individuals past health data, treatments and environmental factors impacting health of individuals of the area. It will also provide the dietary recommendations based on the local environment, culture, and individuals taste and enable them to procure it easily at the best price.

MeFy or MeMe care, as the product is known in the Indian market, means system of behavior passed from one individual to another. Each Me stands for “I” as an individual and as we start building the chain by coming together for the benefits of society, we step together into MeFy, which is Me (I), F= for, Y= you.

Add to bookmarks
ICO KYC Report
Not conducted yet
KYC procedure verifies selected/specific team members only. It does not guarantee ICO success nor is a call for investment.
Missing or incorrect data? Let us know.

ICOs that might interest you

4.6

Mindsync

Mindsync is a platform to solve customer's tasks with AI technologies competitions as w...

12 days 8 hours left
4.4

HiveNet

HiveNet is a distributed cloud computing network, which enables computer owners to rent...

35 days 8 hours left
4.6

PointPay

Crypto Bank, Exchange Launched, Wallet Launched , Payment System. PointPay has created ...

642 days 8 hours left
4.6

Max Crowdfund

Max Crowdfund is an International Real Estate Crowdfunding Platform and Property Manage...

57 days 22 hours left

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn more Got it